Others have demonstrated that chronic treatment of G2019S mice with DSS led to development of PD-like motor impairments22,63 and that DSS coupled with injection of a human alpha-synuclein overexpression vector led to PD-like neurodegeneration in G2019S mice62. Here, SNCA is linked to Parkinson disease.